List view / Grid view
20 October 2015 | By Victoria White
New Phase 3 data show treatment with Janssen’s Stelara (ustekinumab) induced clinical response and clinical remission in patients with moderate to severe Crohn's disease who had previously failed conventional therapy.
20 October 2015 | By Victoria White
In the trial, a significantly greater proportion of patients on Ozanimod achieved or maintained clinical remission at 32 weeks compared with those on placebo...
19 October 2015 | By Victoria White
Nilotinib, a treatment for leukaemia, improved cognition, motor skills and non-motor function in patients with Parkinson's disease in a Phase I clinical trial...
19 October 2015 | By Victoria White
Daiichi Sankyo has said that it will reorganise its US commercial operations from a maturing primary care product portfolio to a differentiated specialty portfolio...
19 October 2015 | By Victoria White
Pfizer’s investigational antibody-drug conjugate inotuzumab ozogamicin has received Breakthrough Therapy designation for acute lymphoblastic leukaemia...
19 October 2015 | By Victoria White
The global treatment market for peripheral artery disease will hit a peak of $983.6 million in 2020, before falling to $816.3 million by 2024 due to the generic erosion of Brilinta and Xarelto...
19 October 2015 | By Victoria White
Praxbind is indicated for patients treated with Pradaxa, when reversal of the anticoagulant effects of Pradaxa is needed for emergency surgery or in uncontrolled bleeding...
19 October 2015 | By Victoria White
Viekirax and Exviera are the first treatments for chronic HCV to combine three direct-acting antiviral agents to target the infection at multiple steps in the viral lifecycle...
16 October 2015 | By Victoria White
Scientists investigating whether the malaria drug artesunate could have a significant impact on colorectal cancer have launched a crowdfunding project to fund their work...
16 October 2015 | By Victoria White
Phase II results show lenvatinib, when used in combination with everolimus, demonstrates significantly improved PFS versus everolimus alone in people with metastatic renal cell carcinoma...
16 October 2015 | By CHI
Largest European Event for Biologics Returns to Lisbon from 2-6 November...
16 October 2015 | By Victoria White
The trials will evaluate the efficacy and safety of intravenous iclaprim versus intravenous vancomycin in the treatment of acute bacterial skin and skin structure infections...
16 October 2015 | By Victoria White
NICE has recommended Daklinza for the treatment of patients with chronic hepatitis C virus genotypes 1, 3 and 4...
16 October 2015 | By Victoria White
Results from an extension study show that long-term onabotulinumtoxinA (Botox) treatment consistently decreased urinary incontinence in female patients...
15 October 2015 | By Sartorius Stedim Biotech
Today, single-use bags are increasingly used in all process steps of biopharmaceutical manufacturing...
